Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 311-316

  Moskowitz, Craig H ^a   Glassman, Jill R ^a   Wuest, David ^a   Maslak, Peter ^a   Reich, Lilian ^a   Gucciardo, Anthony ^a   Coady Lyons, Nancy ^a   Zelenetz, Andrew D ^a   Nimer, Stephen D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PROCARBAZINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; FEMALE; HODGKIN DISEASE; HUMAN; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ERYTHROCYTE TRANSFUSION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LENGTH OF STAY; LEUKAPHERESIS; LYMPHOMA, NON-HODGKIN; MALE; PLATELET TRANSFUSION; TREATMENT OUTCOME;

EID: 0031937912     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Philip, T., Gugliemli, C., Hagenbeck, A., Sommers, K., Lelie, H., Bron, D., Sonneveld, P., Gisslbrecht, C., Cahn, J., Harosseau, J., Coffier, B., Biron, P., Mandelli, F., and Chauvin, F. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New Engl. J. Med., 333: 1540-1545, 1995.
2. Linch, D. C., Winfield, D., Goldstone, A. H., Moir, D., Hancock, B., McMillin, A., Chopra, R., Milligan, D., and Hudson, G. Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet, 341: 1051-1054, 1993.
3. Sheridan, W. P., Begeley, C. G., Juttner, C. A., Szer, J., To, L., Maher, D., McGrath, K., Morstyn, G., and Fox, R. Effect of peripheral blood progenitor cells mobilized by G-CSF on platelet recovery after high dose chemotherapy. Lancet, 339: 640-643, 1992.
4. Kessinger, A., Armitage, J. O., Smith, D. M., Landmark, J., Bierman, P., and Weisenberger, D. High dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood, 74: 1260-1266, 1989.
5. Socinski, M. A., Cannistra, S. A., Elias, A., Antman, K., Schnipper, L., and Griffin, J. GM-CSF expands the circulating hematopoietic progenitor cell compartment in man. Lancet, 28: 1194-1196, 1988.
6. Gianni, A. M., Siena, S., Bregni, M., Tarella, C., Stein, A., Pileri, A., and Bonadanna, G. GM-CSF to harvest circulating hematopoietic stem cells for autotransplantation. Lancet, 334: 580-584, 1989.
7. Yahalom, J., Gulati, S., Toia, M., Maslak, P., McCaron, E., O'Brien, J., Portlock, C., Straus, D., Phillips, J., and Fuks, Z. Accelerated hyperfractionated total lymphoid irradiation, high dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. J. Clin. Oncol., 11: 1062-1070, 1993.
8. Gulati, S., Yahalom, J., Acaba, L., Reich, L., Motzer, R., Crown, J., Toia, M., Igarshi, T., Lemoli, R., Hannien, E., and Doherty, M. Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide and cyclophosphamide and autologous bone marrow transplantation. J. Clin. Oncol., 10: 936-941, 1992.
9. Wheeler, C., Antin, J. H., Churchill, W. H., Come, S., Smith, B., Bubley, G., Rosenthal, I., Rappaport, J., Ault, K., Schnipper, L., and Eder, J. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's Disease and non-Hodgkin's lymphoma. A dose finding study. J. Clin. Oncol., 8: 648-656, 1990.
10. Horning, S. J., Negrin, R. S., Chao, N. J., Long, G., Hoppe, R., and Blume, K. Fractionated total body irradiation, etoposide and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. J. Clin. Oncol., 12: 2252-2258, 1994.
11. Schmitz, N., Linch, D. C., Dreger, P., Goldstone, A., Borgaerts, A., Ferrant, A., Demaynick, H., Link, H., Zander, A., Barge, A., and Borkett, K. Randomized trial of filgrastim-mobilized PBPCT vs ABMT in lymphoma patients. Lancet, 347: 353-357, 1996.
12. Vose, J. M., Anderson, K. R., Kessinger, A., Bierman, P., Coccia, P., Reed, E., Gordon, B., and Armitage, J. High dose chemotherapy and ASCT for aggressive NHL. J. Clin. Oncol., 11: 1846-1851, 1993.
13. Haas, R., Mohle, R., Fruhauf, S., Goldshmidt, H. L. H., Witt, B., Hunstein, M., Wannemacher, M., and Hustein, W. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83: 3787-3795, 1994.
14. Kotasek, D., Shepherd, K. M., Sage, R. E., Dale, B., Norman, J., Charles, P., Gregg, A., Pillow, A., and Bolton, A. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in patients with lymphoma, myeloma and solid tumors. Bone Marrow Transplant., 9: 11-16, 1992.
15. Bensinger, W., Applebaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., and Weaver, C. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J. Clin. Oncol., 13: 2547-2555, 1995.
16. Schneider, J., Crown, J., Wasserheit, C., Kritz, A., Wong, G., Reich, L., Norton, L., and Moore, M. Factors affecting the mobilization of primitive and committed hematopoietic progenitors in the peripheral blood of cancer patients. Bone Marrow Transplant., 14: 877-885, 1994.
17. Dreger, P., Kloss, M., Petersen, B., Huferlach, T., Loffler, H., Loeffler, M., and Schmitz, N. Autologous progenitor cell transplantation: prior exposure to stem cell toxic drugs determines yield and engrafement of peripheral blood progenitor cell but not bone marrow grafts. Blood, 86: 3970-3976, 1995.
18. Tricot, G., Jagannath, S., Vesole, D., Nelson, J., Tindle, S., Miller, L., Cheson, B., Crowley, J., and Barlogie, B. Peripheral blood stem cell transplants from multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood, 85: 588-596, 1995.
19. Olivieri, A., Offidani, M., Ciniero, L., Poloni, A., Masia, M., Salvia, A., and Leoni, P. Optimization of yield of PBSC for autotransplantation mobilized by high dose chemotherapy and G-CSF: proposal for a mathematical model. Bone Marrow Transplant., 14: 273-279, 1994.
20. Moskowitz, C. H., Stiff, P. S., Gordon, M. S., McNiece, I., Ho, A., Costa, J., Brown, E., Bayer, R., Wyes, M., Hill, I., Maxwell, K., Nichols, C., Brown, S., Nimer, S., and Gabrilove, J. Recombinant methionyl stem cell factor and filgrastim for PBPC mobilization and transplantation in non-Hodgkin's lymphoma patients: results of a Phase I/II trial. Blood, 89: 3136-3147, 1997.
21. Shapiro, F., Yao, T. J., Moskowitz, C. H., Reich, L., Wuest, D., Hemfield, S., McAtee, I., Gabrilove, J., Nimer, S., and Moore, M. The effects of prior therapy on the in vitro proliferative potential of SCF plus G-CSF mobilized CD34+ progenitor cells. Clin. Cancer Res., 3: 1571-1579, 1997.
22. Canellos, G. P., Anderson, J. R., Propert, K. J., Nissen, N., Cooper, M., Henderson, E., Green, M., Gottlieb, A., and Peterson, B. Chemotherapy of advanced stage Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. New Engl. J. Med., 327: 1478-1484, 1992.
23. Straus, D. J., Gaynor, J. J., Meyers, J., Merke, D., Carvelli, J., Chapman, D., Yahalom, J., and Clarkson, B. Prognostic factors among 185 adults with newly diagnosed advanced stage Hodgkin's disease treated with alternating potentially non-cross resistant chemotherapy and intermediate dose radiotherapy. J. Clin. Oncol., 8: 1173-1186, 1990.